Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b
作者： Tarak Srivastava , Jeffrey Krudys , Neil J. Mardis , Judith Sebestyen-VanSickle , Uri S. Alon
DOI: 10.1007/S00467-015-3271-7
关键词: Imprinting (psychology) 、 Hormone 、 Internal medicine 、 Nephrology 、 Pseudohypoparathyroidism Type 1b 、 Cinacalcet 、 Endocrinology 、 Medicine 、 In patient 、 Calcium-sensing receptor 、 Parathyroid hormone
摘要: Background In patients with pseudohypoparathyroidism type 1b (PHP1b) due to a tissue-specific imprinting defect in the G-protein α-subunit, skeletal disorders can arise from bones being sensitive parathyroid hormone (PTH) while kidneys remain resistant this hormone.
springer.com
sci-hub.se 参考文章(15)
Uri S. Alon, René G. VanDeVoorde, Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia. Pediatric Nephrology. ,vol. 25, pp. 1747- 1750 ,(2010) , 10.1007/S00467-010-1547-5
Uri S. Alon, Rachel Levy-Olomucki, Wayne V. Moore, Jason Stubbs, Shiguang Liu, L. Darryl Quarles, Calcimimetics as an Adjuvant Treatment for Familial Hypophosphatemic Rickets Clinical Journal of The American Society of Nephrology. ,vol. 3, pp. 658- 664 ,(2008) , 10.2215/CJN.04981107
Jutta Muscheites, Marianne Wigger, Erdmute Drueckler, Dagmar-Christiane Fischer, Guenther Kundt, Dieter Haffner, Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease Pediatric Nephrology. ,vol. 23, pp. 1823- 1829 ,(2008) , 10.1007/S00467-008-0810-5
Farfel Zvi, Pseudohypohyperparathyroidism-pseudohypoparathyroidism type Ib. Journal of Bone and Mineral Research. ,vol. 14, pp. 1016- 1016 ,(1999) , 10.1359/JBMR.1999.14.6.1016
Shermine Dabbagh, Renal-nonresponsive, bone-responsive pseudohypoparathyroidism. A case with normal vitamin D metabolite levels and clinical features of rickets. JAMA Pediatrics. ,vol. 138, pp. 1030- 1033 ,(1984) , 10.1001/ARCHPEDI.1984.02140490030007
R. D. Cohen, F. P. Vince, Pseudohypoparathyroidism with raised plasma alkaline phosphatase. Archives of Disease in Childhood. ,vol. 44, pp. 96- 101 ,(1969) , 10.1136/ADC.44.233.96
M. Koch, M. Kohnle, Successful off-label use of cinacalcet HCl after standard therapy failure in a young man with pseudohypoparathyroidism Type 1b and vitamin D intoxication sequelae. Clinical Nephrology. ,vol. 70, pp. 439- 444 ,(2008) , 10.5414/CNP70439
Tarak Srivastava, Uri S Alon, Cinacalcet as adjunctive therapy for hereditary 1,25‐dihydroxyvitamin D–resistant rickets Journal of Bone and Mineral Research. ,vol. 28, pp. 992- 996 ,(2013) , 10.1002/JBMR.1838
A. Gal-Moscovici, S.M. Sprague, The role of calcimimetics in chronic kidney disease Kidney International. ,vol. 70, ,(2006) , 10.1038/SJ.KI.5001982
Munro Peacock, John P. Bilezikian, Preston S. Klassen, Matthew D. Guo, Stewart A. Turner, Dolores Shoback, Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. ,vol. 90, pp. 135- 141 ,(2005) , 10.1210/JC.2004-0842